Audit 323076

FY End
2023-12-31
Total Expended
$1.30M
Findings
2
Programs
5
Organization: Rural Aids Action Network (MN)
Year: 2023 Accepted: 2024-09-30

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
500299 2023-002 Significant Deficiency - AB
1076741 2023-002 Significant Deficiency - AB

Contacts

Name Title Type
J1GQDEMQRXB7 Mary McCarthy Auditee
3202573036 Wendy Harden Auditor
No contacts on file

Notes to SEFA

Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following, as applicable, either the cost principles in OMB Circular A-122, Cost Principles for Non-Profit Organizations, or the cost principles contained in Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The Organization has elected to use the ten percent de minims indirect cost rate allowed under Uniform Guidance. De Minimis Rate Used: Y Rate Explanation: The auditee used the de minimis cost rate.

Finding Details

Assistance Listing Number 93.917 – HIV Care Formula Grants, award numbers: FAIN#X070028 Compliance Requirements: Activities Allowed or Unallowed, Allowable Costs and Cost Principles Criteria: 2 CFR 200.3030 of Subpart D, “Post Federal Award Requirements Standards for Financial Program Management,” of the Uniform Guidance requires a nonfederal entity to establish and maintain effective internal control over the federal award that provides reasonable assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and the terms and conditions of the federal award, including Activities Allowed or Unallowed and Allowable Costs and Cost Principles. Condition: At times in 2023, approval of expenditures did not follow stated polices, or documentation of approval was not retained. Cause: The Executive Director approves expenditures; however, a process was not consistently in place to show documentation of the approval. At times, approval was done verbally and documentation of the approval was not retained. Effect or Potential Effect: Unallowable costs or activities could be charged to federal grants. Questioned Cost: None Context: As of the date of testing, documented approval was not available for twenty-eight of forty items selected for assistance listing 93.917. Recommendation: We recommend the Organization obtain approval of all expenses by a member of management that did not initiate the expense, prior to the expenses being charged to a federal grant. Planned Corrective Action: We agree in part to this finding. The deficiency exists with approval of transactional funds that are utilized for the transportation and food voucher programs. Historically, authorization to purchase has been deemed as approval and this year some of those documentation processes were not consistently followed, as mentioned being done verbally or during other discussions that were not documented. We did not make any food voucher purchases without discussion prior to purchasing. That being said, we can formalize an approval process that is documented. Additionally, we will review our transportation program policies to ensure that a proper approval process is in place and continues to be supported by the processes we have in place. Name of Contact Person: Drayke Standing Bear, Support Services Coordinator (drayke@raan.org or 320-257-3036) and Courtney Eckstein, Medical Case Management Coordinator (courtney@raan.org or 507-720-2224). Anticipated completion date: December 1, 2024
Assistance Listing Number 93.917 – HIV Care Formula Grants, award numbers: FAIN#X070028 Compliance Requirements: Activities Allowed or Unallowed, Allowable Costs and Cost Principles Criteria: 2 CFR 200.3030 of Subpart D, “Post Federal Award Requirements Standards for Financial Program Management,” of the Uniform Guidance requires a nonfederal entity to establish and maintain effective internal control over the federal award that provides reasonable assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and the terms and conditions of the federal award, including Activities Allowed or Unallowed and Allowable Costs and Cost Principles. Condition: At times in 2023, approval of expenditures did not follow stated polices, or documentation of approval was not retained. Cause: The Executive Director approves expenditures; however, a process was not consistently in place to show documentation of the approval. At times, approval was done verbally and documentation of the approval was not retained. Effect or Potential Effect: Unallowable costs or activities could be charged to federal grants. Questioned Cost: None Context: As of the date of testing, documented approval was not available for twenty-eight of forty items selected for assistance listing 93.917. Recommendation: We recommend the Organization obtain approval of all expenses by a member of management that did not initiate the expense, prior to the expenses being charged to a federal grant. Planned Corrective Action: We agree in part to this finding. The deficiency exists with approval of transactional funds that are utilized for the transportation and food voucher programs. Historically, authorization to purchase has been deemed as approval and this year some of those documentation processes were not consistently followed, as mentioned being done verbally or during other discussions that were not documented. We did not make any food voucher purchases without discussion prior to purchasing. That being said, we can formalize an approval process that is documented. Additionally, we will review our transportation program policies to ensure that a proper approval process is in place and continues to be supported by the processes we have in place. Name of Contact Person: Drayke Standing Bear, Support Services Coordinator (drayke@raan.org or 320-257-3036) and Courtney Eckstein, Medical Case Management Coordinator (courtney@raan.org or 507-720-2224). Anticipated completion date: December 1, 2024